Acesso livre
Acesso livre

Merck autoriza que outros países produzam novo antiviral contra COVID-19.

28 Out, 2021 | 16:17h

Merck to allow other nations to produce new COVID-19 antiviral – CIDRAP

Ver também:

Merck will allow drugmakers in other countries to make its COVID-19 pill – NPR

Game-Changing COVID-19 Oral Treatment Set To Become Widely Accessible in Low- and Middle-Income Countries Upon Regulatory Approval – Health Policy Watch

Conteúdos relacionados:

Video: Merck’s Covid pill could transform treatment. Here’s how it works.

How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.